The Single Best Yield-Plus-Dividend Growth Stock

Last week, one of my favorite income stocks issued a press release with its preliminary third-quarter results. This business development company (BDC) extended its long tenure as the best company and stock in the category. If there ever were a…

An Unprecedented Moment for a New Crypto Commodity

In the previous parts of our “Why Diamonds?” series, we explained that as an uncorrelated and under-allocated asset, diamonds can play an important role in investor portfolios. In this final installment, we describe how the unique characteristics of diamonds combined…

An Under-Allocated Investment with Pent-Up Demand

Diamonds are a $1.2 trillion natural resource, more than silver and platinum combined. As a durable hard-asset, diamonds are just like precious metals and a reliable store of wealth. In the first part of our “Why Diamonds?” series, we shared insights on…

1 Biotech Stock Looking To Make A Big Move

MoonLake Immunotherapeutics (MLTX) is the latest stock to give us a setup that works well within our system and you’ll see why once you take a look at the chart in the video below. In perhaps one of our cleanest setups…